What does “Leukine” cost (list price and typical pricing)?
“Leukine” is a brand name for sargramostim, a granulocyte-macrophage colony-stimulating factor (GM-CSF) used to help treat certain patients with low white blood cell counts. Pricing is not fixed and can vary a lot based on the country, the specific product strength/package, and the payer (self-pay vs. commercial insurance vs. government programs). The provided information here doesn’t include any specific price figures for Leukine.
Why can Leukine price vary so much?
Even when the drug is the same, the out-of-pocket and billed cost can change due to:
- Dose and treatment length (GM-CSF is weight/indication-dependent, so total course cost can swing widely).
- Package size and vial strength (people compare different pack sizes).
- Contracted hospital/clinic pricing vs. pharmacy retail pricing.
- Insurance coverage tiers and prior authorization requirements.
- Specialty pharmacy pricing and dispensing fees.
How much might you pay out of pocket?
Out-of-pocket cost depends heavily on whether you’re billed as a specialty pharmacy prescription or administered in a clinic/hospital setting, and on your insurance deductible/co-insurance. Without the dosage, country, and whether it’s inpatient/clinic vs. home infusion, a single “Leukine price” number would be misleading.
What’s the fastest way to get an accurate Leukine price for your situation?
If you share these details, a more precise estimate can be assembled:
- Your country (and whether this is for a prescription or clinic administration)
- Strength and package you’re seeing (e.g., vial size)
- Your prescribed dose and how many days/weeks
- Whether you have insurance (and if so, the plan type), or if you’re paying cash
Are there cheaper alternatives (biosimilars/generics) if price is the main concern?
If cost is the issue, the practical next step is to ask your prescriber/pharmacy whether there are lower-cost alternatives or therapeutically equivalent GM-CSF options available in your market. Availability depends on local approvals and formularies, and the provided information here doesn’t list competitors or biosimilar options for Leukine.
---
Sources:
No sources were provided with your request, so no Leukine price data could be cited.